Evidence map›Paper›PMID 29062739›Full record

ReviewAnnals of cardiothoracic surgery2017

Pros and cons of transcatheter aortic valve implantation (TAVI).

Juan A Terré, Isaac George, Craig R Smith

Open access · diamondAbstract readReview
In one paragraph

Review in Annals of cardiothoracic surgery, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 45 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Review
  5. Review
  6. Article
  7. CardioVision: A fully automated deep learning package for medical image segmentation and reconstruction generating digital twins for patients with aortic stenosis.Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society · 2023
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. TAVI imaging: over the echocardiography.La Radiologia medica · 2020
    Review
  14. Review
  15. Article
  16. TAVI-thick on technology but thin on evidence.Indian journal of thoracic and cardiovascular surgery · 2019
    Review
  17. Outcomes of transcatheter aortic valve replacement in patients with mitral valve regurgitation.Postepy w kardiologii interwencyjnej = Advances in interventional cardiology · 2019
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Juan A TerréNew York Presbyterian Hospital-Columbia University Medical Center, New York, NY, USA.
Isaac GeorgeNew York Presbyterian Hospital-Columbia University Medical Center, New York, NY, USA.
Craig R SmithNew York Presbyterian Hospital-Columbia University Medical Center, New York, NY, USA.
Columbia University Irving Medical Center · USNew York Hospital Queens · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transcatheter aortic valve implantation (TAVI) or replacement (TAVR) was recently approved by the FDA for intermediate risk patients with severe aortic stenosis (AS). This technique was already worldwide adopted for inoperable and high-risk patients. Improved device technology, imaging analysis and operator expertise has reduced the initial worrisome higher complications rate associated with TAVR, making it comparable to surgical aortic valve replacement (SAVR). However, many answers need to be addressed before adoption in lower risk patients. This paper highlights the pros and cons of TAVI based mostly on randomized clinical trials involving the two device platforms approved in the United States. We focused our analysis on metrics that will play a key role in expanding TAVR indication in healthier individuals. We review the significance and gave a perspective on paravalvular leak (PVL), valve performance, valve durability, leaflet thrombosis, stroke and pacemaker requirement.

Indexed as

leaflet thrombosispacemakerparavalvular leak (PVL)paravalvular regurgitationreviewstrokesurgical aortic valve replacement (SAVR)Transcatheter aortic valve implantation (TAVI)transcatheter aortic valve replacement (TAVR)

Identifiers

PMID29062739
PMCPMC5639221
OpenAlexW2758282779

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.